Your browser doesn't support javascript.
loading
Cytoreductive nephrectomy and exposure to sunitinib - a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial.
Abu-Ghanem, Yasmin; van Thienen, Johannes V; Blank, Christian; Aarts, Maureen J B; Jewett, Michael; de Jong, Igle Jan; Lattouf, Jean-Baptiste; van Melick, Harm H E; Wood, Lori; Mulders, Peter; Rottey, Sylvie; Wagstaff, John; Zondervan, Patricia; Powles, Tom; Neven, Anouk; Collette, Laurence; Tombal, Bertrand; Haanen, John; Bex, Axel.
Afiliação
  • Abu-Ghanem Y; Royal Free London NHS Foundation Trust and UCL Division of Surgery and Interventional Science, London, UK.
  • van Thienen JV; Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Blank C; Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Aarts MJB; Maastricht University Medical Center, Maastricht, the Netherlands.
  • Jewett M; Princess Margaret Hospital, Toronto, ON, Canada.
  • de Jong IJ; University of Groningen, University Medical Center Groningen, the Netherlands.
  • Lattouf JB; University of Montreal Hospital Center, Montreal, QC, Canada.
  • van Melick HHE; Saint Antonius Hospital, Nieuwegein, the Netherlands.
  • Wood L; QEII Health Sciences Center, Halifax, NS, Canada.
  • Mulders P; Radboud University Hospital, Nijmegen, the Netherlands.
  • Rottey S; Ghent University Hospital, Ghent, UK.
  • Wagstaff J; South West Wales Cancer Centre and Swansea University College of Medicine, Swansea, UK.
  • Zondervan P; University Medical Centers, Amsterdam, the Netherlands.
  • Powles T; Barts and Queen Mary University London, London, UK.
  • Neven A; European Organisation of Research and Treatment of Cancer (EORTC), Brussels, Belgium.
  • Collette L; European Organisation of Research and Treatment of Cancer (EORTC), Brussels, Belgium.
  • Tombal B; European Organisation of Research and Treatment of Cancer (EORTC), Brussels, Belgium.
  • Haanen J; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Bex A; Netherlands Cancer Institute, Amsterdam, the Netherlands.
BJU Int ; 130(1): 68-75, 2022 07.
Article em En | MEDLINE | ID: mdl-34706141
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: BJU Int Assunto da revista: UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: BJU Int Assunto da revista: UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido